Aeluma, Inc. (ALMU)
NASDAQ: ALMU · Real-Time Price · USD
16.14
-0.29 (-1.77%)
At close: Dec 5, 2025, 4:00 PM EST
16.29
+0.15 (0.94%)
After-hours: Dec 5, 2025, 7:55 PM EST
Company Description
Aeluma, Inc. develops optoelectronic and electronic devices for sensing, communication, and computing applications in the United States.
The company produces semiconductor materials and chips using compound semiconductors on diameter substrates that are used to manufacture mass market microelectronics.
Its products are used in mobile, automotive, AI, defense and aerospace, communication, AR/VR, high-performance commuting, and quantum computing applications, as well as other electronic and optoelectronic devices, including lasers, transistors, and solar cells.
Aeluma, Inc. was founded in 2019 and is headquartered in Goleta, California.
Aeluma, Inc.
| Country | United States |
| Founded | 2019 |
| Industry | Semiconductors |
| Sector | Technology |
| Employees | 14 |
| CEO | Jonathan Klamkin |
Contact Details
Address: 27 Castilian Drive Goleta, California 93117 United States | |
| Phone | 805 351 2707 |
| Website | aeluma.com |
Stock Details
| Ticker Symbol | ALMU |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001828805 |
| ISIN Number | US00776X1090 |
| Employer ID | 85-2807351 |
| SIC Code | 3674 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jonathan Klamkin Ph.D. | Chief Executive Officer, President and Chairman |
| Christopher P. Stewart | Chief Financial Officer |
| Dr. Matthew Dummer Ph.D. | Director of Technology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 2, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 2, 2025 | DEF 14A | Other definitive proxy statements |
| Nov 25, 2025 | 424B3 | Prospectus |
| Nov 21, 2025 | EFFECT | Notice of Effectiveness |
| Nov 19, 2025 | POS AM | Post-Effective amendments for registration statement |
| Nov 14, 2025 | 424B3 | Prospectus |
| Nov 14, 2025 | 424B3 | Prospectus |
| Nov 14, 2025 | SCHEDULE 13G/A | Filing |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | 8-K | Current Report |